Publisher Correction: Reduction of liver fibrosis by rationally designed macromolecular telmisartan prodrugs.
Where this comes from
- Record sourced from PubMed, PMID 31015683.
- Also identified by DOI 10.1038/s41551-018-0299-6.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In the version of this Article originally published, the author Peter Blume-Jensen was not denoted as a corresponding author; this has now been amended and the author's email address has been added. The 'Correspondence and requests for materials' statement was similarly affected and has now been updated with the author's initials 'P.B-J.'